The stock hit a high of Rs. 1,580 and a low of Rs. 1,536 on BSE today.
Natco Pharma is trading higher on the BSE on the back of launching Hepatitis C drug in Nepal.
The company today informed the BSE that it has launched the first generic version of sofosbuvir in Nepal, which is used for chronic hepatitis C infection.
The stock opened with a gain of 1.5 per cent at Rs. 1,536. So far, the stock has jumped to a high of Rs. 1,580 - up 4.4 per cent from its previous close.
Now, the stock is up 3 per cent at Rs. 1,566. The BSE counter has registered trades of around 11,000 shares, as against two-week daily average volume of 7,431 shares.
Meanwhile, the Sensex has plunged 381 points at 29,068.
The company today informed the BSE that it has launched the first generic version of sofosbuvir in Nepal, which is used for chronic hepatitis C infection.
The stock opened with a gain of 1.5 per cent at Rs. 1,536. So far, the stock has jumped to a high of Rs. 1,580 - up 4.4 per cent from its previous close.
Now, the stock is up 3 per cent at Rs. 1,566. The BSE counter has registered trades of around 11,000 shares, as against two-week daily average volume of 7,431 shares.
Meanwhile, the Sensex has plunged 381 points at 29,068.
No comments:
Post a Comment